About Saitama Children's Medical Center
埼玉県立小児医療センターは、埼玉県さいたま市中央区新都心にある小児専門病院である。かつては同市岩槻区大字馬込に所在していた。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Saitama Children's Medical Center
During the past decade, Saitama Children's Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on
average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saitama Children's Medical Center" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Takeda" with 3 trials
sponsored, "Amgen" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Reata Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Children's Medical Center"
#1 collaborator was "Amgen Astellas Biopharma K.K." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Saitama Children's Medical Center
According to Clinical.Site data, the most researched conditions in "Saitama Children's Medical Center" are
"Juvenile Idiopathic Arthritis" (2 trials), "Ulcerative Colitis" (2 trials), "Alagille Syndrome (ALGS)" (1 trials), "Alport Syndrome" (1 trials) and "Autosomal Dominant Polycystic Kidney" (1 trials). Many other conditions were trialed in "Saitama Children's Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Saitama Children's Medical Center
Most popular intervention types in "Saitama Children's Medical Center" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Baricitinib" (2 trials), "TAK-625" (2 trials), "Bardoxolone methyl" (1 trials), "Blinatumomab" (1 trials) and "Insulin Degludec" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saitama Children's Medical Center
The vast majority of trials in "Saitama Children's Medical Center" are
11 trials for "All" genders.
Clinical Trials Status at Saitama Children's Medical Center
Currently, there are NaN active trials in "Saitama Children's Medical Center".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Saitama Children's Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Children's Medical Center, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Saitama Children's Medical Center
Saitama Children's Medical Center has several departments that took part in Clinical trials: "Saitama Cancer Center" - 45 trials